BNP Paribas Financial Markets Sells 14,003 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
BNP Paribas Financial Markets trimmed its position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 43.7% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 18,075 shares of the biotechnology company’s stock after selling 14,003 shares during the period. BNP Paribas Financial Markets’ holdings in Aurinia Pharmaceuticals were worth $162,000 […]
BNP Paribas Financial Markets trimmed its position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 43.7% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 18,075 shares of the biotechnology company’s stock after selling 14,003 shares during the period. BNP Paribas Financial Markets’ holdings in Aurinia Pharmaceuticals were worth $162,000 […]
